Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.03 BRL | +0.67% | +0.67% | -12.38% |
Mar. 04 | Barclays Downgrades Ambev to Equalweight From Overweight, Adjusts Price Target to $3 From $3.50 | MT |
Feb. 29 | Transcript : Ambev S.A., Q4 2023 Earnings Call, Feb 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.38% | 36.9B | |
-3.39% | 119B | |
+384.45% | 67.41B | |
-0.54% | 55.17B | |
+7.57% | 47.58B | |
-0.91% | 23.13B | |
+13.27% | 19.06B | |
-23.67% | 18.42B | |
+3.94% | 17.59B | |
+4.53% | 15.06B |
- Stock Market
- Equities
- ABEV3 Stock
- News Ambev S.A.
- Ambev's Q4 Normalized Earnings, Revenue Decline